CIK: 0001388551 · Show all filings
Period: Q3 2020 (← Previous) (Next →)
Filing Date: Nov 16, 2020
Total Value ($000): $106,064 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| CRDF | CARDIFF ONCOLOGY INC | 1,845,164 | $26,183 | 24.7% | $2.66 | +147.9% | COM | 14147L108 |
| — | MOLECULAR TEMPLATES INC | 2,122,991 | $23,183 | 21.9% | $8.09 | — | COM | 608550109 |
| — | STRONGBRIDGE BIOPHARMA PLC | 8,089,442 | $16,988 | 16.0% | $2.77 | — | SHS USD | G85347105 |
| — | CTI BIOPHARMA CORP | 4,313,617 | $9,274 | 8.7% | $2.01 | — | COM | 12648L601 |
| — | SIERRA ONCOLOGY INC | 643,959 | $6,871 | 6.5% | $9.82 | — | COM NEW | 82640U404 |
| — | KALA PHARMACEUTICALS INC | 771,790 | $5,788 | 5.5% | $6.33 | — | COM | 483119103 |
| GLD | SPDR GOLD TR | 25,358 | $4,491 | 4.2% | $170.99 | — | GOLD SHS | 78463V107 |
| — | GARRISON CAP INC | 1,164,061 | $4,447 | 4.2% | $8.25 | — | COM | 366554103 |
| SCYX | SCYNEXIS INC | 834,370 | $3,680 | 3.5% | $6.12 | 0.0% | COM NEW | 811292200 |
| — | PERSHING SQUARE TONTINE HLDG | 67,369 | $1,529 | 1.4% | $22.70 | — | COM CL A | 71531R109 |
| — | IVERIC BIO INC | 192,738 | $1,087 | 1.0% | $5.29 | — | COM | 46583P102 |
| — | EIGER BIOPHARMACEUTICALS INC | 112,872 | $919 | 0.9% | $9.68 | — | COM | 28249U105 |
| — | CHURCHILL CAPITAL CORP IV | 62,500 | $626 | 0.6% | $10.02 | — | UNIT 99/99/9999 | 171439201 |
| — | MEI PHARMA INC | 175,560 | $548 | 0.5% | $3.83 | — | COM NEW | 55279B202 |
| — | ADDEX THERAPEUTICS LTD | 17,398 | $213 | 0.2% | $6.60 | — | SPONSORED ADS | 00654J107 |
| — | ESSA PHARMA INC | 26,590 | $183 | 0.2% | $6.88 | — | COM NEW | 29668H708 |
| — | PERSHING SQUARE TONTINE HLDG | 7,485 | $54 | 0.1% | $7.21 | — | *W EXP 07/24/202 | 71531R117 |